AUS
NZ
UK
CA
USA
FRA
GER
ESP
ITA
NLD
PRT
SWE
GRC
IND
POL
BRA
ZAF
RUS
CHN
UAE
Healthcare
Kalkine: Neuren Pharmaceuticals Delivers Strong Growth and Expansion Plans Amid ASX200 Momentum
May 27, 2025 03:13 PM AEST| By Team Kalkine MediaHighlights,Neuren posts A$166 million record income,DAYBUE drives global expansion outlook,Promising clinical trials support future pipeline,Neuren Pharmaceuticals (ASX:NEU) has made headlines with a remarkable financial performance for the year 2024...
Kalkine: PainChek Expands US Presence with Eldermark Partnership, Eyes Growth Ahead of ASX200 Inclusion
May 27, 2025 01:22 PM AEST| By Team Kalkine MediaHighlights,PainChek,teams up with,Eldermark,to grow US market reach,Integration to deliver AI-driven pain assessments in real-time,FDA clearance to unlock full-scale sales rollout,PainChek (ASX:PCK),has entered a strategic partnership with Eldermark...
Kalkine: Prescient Therapeutics (ASX:PTX) Advances Rare Blood Cancer Treatment with Phase 2a Trial Amid ASX200 Momentum
May 27, 2025 12:42 PM AEST| By Team Kalkine MediaHighlights:,Phase 2a study initiated for PTX-100 in rare Cutaneous T-Cell Lymphoma,Trial spans Australia, US, and Europe with up to 40 patients,PTX-100 targets unmet need in relapsed or refractory CTCL,Prescient Therapeutics (ASX:PTX) has reached a s...
ASX 200 Healthcare Giants: Performance Snapshot of CSL, SIG, PME, RMD, and FPH
May 26, 2025 05:26 PM AEST| By Team Kalkine MediaHighlights,CSL (ASX:CSL) shows modest gains while maintaining its leadership in biopharmaceuticals,SIG (ASX:SIG) continues to lead pharmacy distribution despite a slight decline,PME (ASX:PME) and RMD (ASX:RMD) experience minor pullbacks amid strong a...
Healthscope’s Future in the ASX300: No Taxpayer Bailout, Government Confirms
May 26, 2025 03:34 PM AEST| By Team Kalkine MediaHighlights,Government will not provide taxpayer bailout to Healthscope.,Patient care and hospital integrity remain top priorities.,Focus on orderly sale to protect all stakeholders.,The Australian Government has made it clear that Healthscope (ASX:HS...
ASX 200 Healthcare Shock: ASX:CBA Supports Healthscope Amid Receivership
May 26, 2025 02:49 PM AEST| By Team Kalkine MediaHighlights,Healthscope enters voluntary receivership amid severe financial strain and debt concerns,Commonwealth Bank of Australia (ASX:CBA) offers financial support to maintain hospital operations,Landlords issue breach notices as tenancy defaults e...
Recce Pharmaceuticals (ASX:RCE) Strengthens Patent Portfolio with Chinese Approval, Boosting Presence in ASX200 Pharma Sector
May 26, 2025 12:57 PM AEST| By Team Kalkine MediaHighlights,Recce secures patent approval in China for key anti-infective drug candidates.,Patent covers multiple bacterial and viral infections with varied administration methods.,Expansion enhances Recce’s global intellectual property footprint in m...
Which Healthcare Leader in the S&P/ASX Two Hundred and ASX All Ordinaries Tops Global Fund Holdings?
May 23, 2025 06:18 PM AEST| By Team Kalkine MediaWhich Healthcare Leader in the S&P/ASX Two Hundred and ASX All Ordinaries Tops Global Fund Holdings?
ASX 200 Health Stocks Climb Amid Capital Raisings and Diagnostic Advancements
May 23, 2025 04:31 PM AEST| By Team Kalkine MediaHighlights:,Multiple ASX-listed healthcare firms initiate capital raisings to strengthen cash positions,EMVision showcases improved stroke diagnostic performance using AI at major health conference,Monash IVF updates FY25 outlook following operationa...
Mayne Pharma (ASX:MYX) Shares Show Partial Rebound Amid Takeover Uncertainty and ASX200 Volatility
May 23, 2025 02:41 PM AEST| By Team Kalkine MediaHighlights,Mayne Pharma shares recover after sharp weekly decline,FDA concerns impact takeover negotiations with US firm Cosette,Market watchers eye implications for ASX dividend stocks and ASX200,Mayne Pharma (ASX:MYX) shares experienced a partial r...
Hengrui’s Soaring Hong Kong Debut Sparks Optimism Across ASX200 and Global Pharma Markets
May 23, 2025 12:27 PM AEST| By Team Kalkine MediaHighlights,Hengrui jumps 29% in Hong Kong listing,$2 billion capital to fuel drug innovation,Market buzz adds momentum to ASX200,In a remarkable debut that has stirred enthusiasm among global investors,,Jiangsu Hengrui Pharmaceuticals (HKG:600276),,...
Nyrada’s Breakthrough TRPC Blocker Gains Momentum in ASX200 Medical Research Space
May 23, 2025 12:00 AM AEST| By Team Kalkine MediaHighlights,Drug shows promise for stroke, heart attack, and brain injury,Early trial data confirms safety and strong tissue preservation,Anti-arrhythmic effects observed in follow-up studies,Nyrada Inc. (ASX:NYR) has reported encouraging progress on...
Regeneron (NASDAQ:REGN) Moves to Acquire 23andMe Amid Market Shifts — What ASX200 Investors Should Know
May 23, 2025 12:00 AM AEST| By Team Kalkine MediaHighlights,Regeneron to acquire 23andMe’s core assets for $256 million,Customer DNA data security prioritized in the deal,Acquisition aligns with growing biotech innovation in ASX200 and beyond,Biotechnology leader Regeneron Pharmaceuticals (NASDAQ:R...
Could Mayne Pharma’s Deal Review Rattle ASX 200 and Health Care Index?
May 22, 2025 03:30 PM AEST| By Team Kalkine MediaCould Mayne Pharma’s Deal Review Rattle ASX 200 and Health Care Index?
Mayne Pharma Shares Hit New Low as ASX200 Pressure Mounts
May 22, 2025 01:42 PM AEST| By Team Kalkine MediaHighlights,Mayne Pharma faces steep decline amid investor uncertainty,FDA letter adds pressure as Cosette Pharmaceuticals reconsiders deal,Shares down over 39% since April peak,Mayne Pharma (ASX:MYX) continues to face headwinds as its shares hit fres...
Could AFT Pharmaceuticals Boost ASX and S&P Health Care Index Momentum?
May 22, 2025 10:30 AM AEST| By Team Kalkine MediaCould AFT Pharmaceuticals Boost ASX and S&P Health Care Index Momentum?
Pro Medicus (ASX:PME) Surges in ASX300: Exploring Healthcare Tech’s Strong Momentum
May 21, 2025 01:49 PM AEST| By Team Kalkine MediaHighlights,Pro Medicus sees double-digit growth in early 2025,Healthcare tech shines amid global sector momentum,PME valuation reflects rising demand for radiology software,Pro Medicus Ltd (ASX:PME), a leading name in medical imaging software, has co...
ASX 200 Financial Sector Watch: CBA, MYX, ADT in Spotlight Amid Index Fluctuations
May 21, 2025 01:30 PM AEST| By Team Kalkine MediaHighlights:,Commonwealth Bank (ASX:CBA) reaches a historic intraday high despite market uncertainties,Mayne Pharma (ASX:MYX) experiences steep decline following takeover withdrawal,Adriatic Metals (ASX:ADT) records share surge amid acquisition intere...
ASX200 Update: Nanosonics (ASX:NAN) Shares Climb Amid Market Query
May 21, 2025 12:47 PM AEST| By Team Kalkine MediaHighlights,Nanosonics,shares rise after addressing ASX query,Company unaware of reasons behind unusual trading activity,Previous,share movement linked to FDA approval in March,Shares of medical device firm Nanosonics (ASX:NAN) saw a notable rebound a...
ASX200 M&A Drama: Why Cosette Abandoned Its $672M Mayne Pharma Deal
May 21, 2025 12:40 PM AEST| By Team Kalkine MediaHighlights,Private equity bidder Cosette exits deal citing earnings and regulatory issues,Mayne Pharma's (MYX) stock tumbles 30% amid legal tussle,Market volatility, earnings downgrade, and FDA scrutiny shake confidence,In a dramatic turn of events t...
Advertise your brand on Kalkine Media